University Hospital 12 de Octubre Reports Findings in Artificial Intelligence (Assessment of PD-L1 expression and tumour infiltrating lymphocytes in early-stage non-small cell lung carcinoma with artificial intelligence algorithms)

扫码查看

原文链接

NETL
NSTL

外文摘要：By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News – New research on Artificial Intelligence is the su bject of a report. According to news reporting originating in Madrid, Spain, by NewsRx journalists, research stated, “To study programmed death ligand 1 (PD-L1) expression and tumour infiltrating lymphocytes (TILs) in patients with early-stage non-small cell lung carcinoma (NSCLC) with artificial intelligence (AI) algorithms. The study included samples from 50 early-stage NSCLCs.”

外文关键词：

MadridSpainEuropeAlgorithmsArtificial IntelligenceBlood CellsBronchial NeoplasmsBronchogenic CarcinomaCancerCarcinomasEmerging TechnologiesHealth and MedicineHemic and Immune SystemsImmunologyLung Diseases and ConditionsLung NeoplasmsLymphocytesMachine LearningMononuclear LeukocytesNon-Small Cell Lung CancerNon-Small- Cell Lung CancerOncologyPathologyRespiratory Tract Diseases and ConditionsRespiratory Tract NeoplasmsSmall Cell CarcinomaSmall Cell Lung Cancer

出版年：

2024

Robotics & Machine Learning Daily News

ISSN：

年,卷(期)：2024.(Oct.24)